CRLBF logo

CRLBF
Cresco Labs Inc

7,555
Mkt Cap
$450.61M
Volume
456,193.00
52W High
$2.30
52W Low
$0.4256
PE Ratio
-8.53
CRLBF Fundamentals
Price
$1.26
Prev Close
$1.23
Open
$1.19
50D MA
$1.07
Beta
1.00
Avg. Volume
2.11M
EPS (Annual)
-$0.2155
P/B
1.05
Rev/Employee
$249,773.45
Loading...
Loading...
News
all
press releases
Should You Buy GTBIF Stock After Marijuana Reclassification Order?
Shares of Green Thumb GTBIF jump nearly 35% on a marijuana rescheduling order, but pricing pressure and weak comps cloud the stock's near-term outlook.
Zacks·12d ago
News Placeholder
More News
News Placeholder
Tilray Brands Strengthens Domestic Lead With Strong Q1 Cannabis Growth
TLRY posts a strong quarter as Canadian cannabis revenues grow and market shares climb across key product categories.
Zacks·1mo ago
News Placeholder
TLRY vs. CRLBF: Which Cannabis Player Offers Greater Upside?
Tilray Brands' global expansion and strong Canadian momentum spotlight its edge as investors weigh upside against Cresco Labs' slower growth.
Zacks·1mo ago
News Placeholder
Cresco Labs Expands Operations Beyond U.S.: How to Play the Stock?
CRLBF's move into Germany opens a new growth path as it navigates U.S. pricing pressure and rising competition in its core market.
Zacks·2mo ago
News Placeholder
Cresco Labs Inc. (CRLBF) Reports Q3 Loss, Beats Revenue Estimates
Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of -66.67% and +0.71%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
New Strong Sell Stocks for Oct. 17th
GYRE, DAR and CRLBF have been added to the Zacks Rank #5 (Strong Sell) List on October 17, 2025.
Zacks·3mo ago
News Placeholder
Cannabis Stock CRLBF Gains 25% in a Month: Time to Buy, Sell or Hold?
CRLBF surges 25% this month on reform hopes, but revenue declines, margin pressure and stiff competition cloud its outlook.
Zacks·4mo ago
News Placeholder
Cresco Labs Inc. (CRLBF) Reports Q2 Loss, Lags Revenue Estimates
Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of -25.00% and -0.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5mo ago
News Placeholder
Perrigo (PRGO) Lags Q2 Earnings and Revenue Estimates
Perrigo (PRGO) delivered earnings and revenue surprises of -3.39% and -2.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5mo ago
News Placeholder
Exagen Inc. (XGN) Reports Q2 Loss, Beats Revenue Estimates
Exagen (XGN) delivered earnings and revenue surprises of 0.00% and +7.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5mo ago
<
1
2
...
>

Latest CRLBF News

View

Advertisement|Remove ads.

Advertisement|Remove ads.